Developer docs
API playgroundTry for free, no card

Search company profiles

Amy's Foundation

Full company profile

uuid003grg8

Namestring
Amy's Foundation
Legal namestring
Amy's Foundation, Inc
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Amy's Foundation is a 501(c)(3) nonprofit organization established in 2024 in Fort Wayne, Indiana, by Ron Martin in memory of his late wife Amy Louise Daniels Martin, who carried a BRCA-1 gene mutation and died of ovarian cancer in January 2024. The foundation's singular mission is to fund the development of the first early detection test for ovarian cancer, addressing the gap left by the absence of a screening tool comparable to mammography or Pap smears — a gap that contributes to a 30% five-year survival rate versus 90% for breast cancer and 92% for cervical cancer. The foundation operates a community-driven fundraising model, channeling donations through its website, a Venmo account (@amysfoundation), and the Generosity payment processor, with both one-time and recurring tiers starting at $1 monthly.

The organization's core product is research funding directed to Cleveland Clinic, specifically supporting Dr. Mariam AlHilli's study on integrin/syndecan signaling pathways as potential biomarkers for early detection in BRCA mutation carriers. Its secondary programs include the Amy's Allies volunteer advocacy program, which recruits ovarian cancer survivors and supporters to share personal stories on Instagram, Facebook, LinkedIn, YouTube, and TikTok, and a Salesforce-managed email/newsletter channel used for donor cultivation. The foundation has no proprietary technology product and does not sell goods or services; all revenue derives from charitable donations.

As of the first funding cycle, the foundation has raised approximately $17,482 from 318 donations against a $25,000 goal, deployed a 1-10 employee founder-led operating model, and operates exclusively within the United States. Competitive positioning rests on a tightly focused disease mandate, a personal founder narrative, and a named institutional research partner, rather than on scale advantages or distribution dominance in the broader nonprofit sector.

Short descriptiontext

Amy's Foundation is a 501(c)(3) nonprofit founded in 2024 in Indiana that funds ovarian cancer early detection research at Cleveland Clinic via community-driven donations, recurring giving, and a survivor advocacy program.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersFort Wayne, United States
HQ citystring
Fort Wayne
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ovarian cancer research, nonprofit fundraising, early detection research, cancer advocacy, 501(c)(3) foundation
Industry2 codes
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
NAICS code2 codes
  • Voluntary Health Organizations813212
  • Grantmaking Foundations813211
Product category
Ovarian Cancer Research Nonprofit Foundation
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Donations
TypeGrants Donations
Description

The organization accepts one-time and recurring donations through a secure third-party payment processor (Generosity). Donations are tax-deductible as the organization is a 501(c)(3) nonprofit.

amysfoundation.org
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Marketing or Sales, Technology or R&D, Personnel, Others
Pricing details2 tiers
1First Funding Cycle goal of $25,000 for early detection research
ModelOtherBilling cadenceOne time
Notes

Current fundraising: $17,482 raised (70% of goal) from 318 donations. Suggested one-time amounts: $25, $50, $100, $250

amysfoundation.org
2Recurring donation options for monthly supporters
ModelSubscriptionBilling cadenceMonthly
Notes

Weekly options: $1.03, $5, $10. Monthly options: $1, $25, $50, $100, $250. Donors can add $0.03 to cover transaction fees.

amysfoundation.org
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Amy's Foundation is a 501(c)(3) nonprofit that raises funds to support Cleveland Clinic's research, led by Dr. Mariam AlHilli, aimed at developing the first early detection test for ovarian cancer, with focus on integrin/syndecan biomarkers in BRCA mutation carriers. The foundation collects one-time and recurring donations through its website and Venmo, and runs the Amy's Allies social advocacy program to spread awareness.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Currently at 70% of first $25,000 funding goal for Cleveland Clinic research
+1 more record
Product overview1 text field

Amy's Foundation is a 501(c)(3) nonprofit organization focused on funding ovarian cancer early detection research. The organization operates primarily through its website platform, which combines donation collection (via one-time and recurring donation programs) with research advocacy. The core product is funding for Cleveland Clinic's ovarian cancer research, led by Dr. Mariam AlHilli, specifically targeting the development of the first early detection test for ovarian cancer. Supporting offerings include the Amy's Allies social advocacy program where volunteer survivors amplify awareness through social media.

Product and service4 records
1Ovarian Cancer Research Funding
CategoryCore Program
Description

The foundation's primary mission product: funding Cleveland Clinic's research led by Dr. Mariam AlHilli to develop the first early detection test for ovarian cancer, including the investigation of integrin/syndecan biomarkers in BRCA mutation carriers.

2Donation Platform
CategoryFundraising Product
Description

Website-based fundraising platform accepting one-time donations to fund ovarian cancer early detection research, processed through the third-party Generosity payment processor.

3Recurring Donation Program
CategoryFundraising Product
Description

Monthly and weekly giving program allowing donors to contribute recurring amounts starting at $1 per week or month, with options to cover transaction fees, supporting ongoing ovarian cancer research funding.

4Amy's Allies Program
CategoryAdvocacy Program
Description

Volunteer social media advocacy program where ovarian cancer survivors and supporters use their digital platforms to spread awareness, share resources, and amplify the foundation's mission year-round and during Ovarian Cancer Awareness Month.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Amy's Foundation is raising funds to support Cleveland Clinic's groundbreaking research to develop the first early detection test for ovarian cancer. The research is led by Dr. Mariam AlHilli and focuses on investigating integrin/syndecan signaling pathways as potential biomarkers for early detection in BRCA mutation carriers. The study aims to examine ovarian tissues and blood samples to identify new detection methods.

2Dr. Mariam AlHilli
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Mariam AlHilli is the lead researcher at Cleveland Clinic conducting the early detection ovarian cancer study. Her team is investigating whether changes in cell signaling (integrin/syndecan) found in breast tissues of BRCA mutation carriers are also present in ovarian tissues and whether these changes can serve as new biomarkers for early detection.

amysfoundation.org
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large disease-specific research grantmaking foundation operating a model very similar to Amy's Foundation (donor-funded research grants to academic medical centers), but at vastly greater scale and focused on breast cancer. Useful benchmark for the scale trajectory Amy's Foundation could pursue.

TypeDirect peer
Description

Largest U.S. nonprofit focused exclusively on ovarian cancer, combining research grantmaking with advocacy and patient support. Directly comparable mission (funding ovarian cancer research) and donor-driven nonprofit model.

TypeDirect peer
Description

Venture-style cancer research grantmaking foundation funding investigator-initiated studies across multiple cancer types. Comparable grantmaking nonprofit model, though broader in scope and substantially larger.

TypeDirect peer
Description

Long-standing ovarian cancer nonprofit funding research, awareness, and survivor support programs. Mirrors Amy's Foundation's combination of research funding and survivor-led awareness, though at much larger scale.

5American Cancer Society
TypeBroad incumbent
Description

Largest U.S. cancer nonprofit funding broad research, including ovarian cancer programs. Overlaps with Amy's Foundation in donor pool and research grantmaking category but competes for the same ovarian cancer research dollars at vastly larger scale.

TypeRegional player
Description

Canadian national charity dedicated to ovarian cancer research, awareness, and support. Direct mission peer, but operates in a different geography (Canada vs. U.S.) and therefore does not compete for the same donor pool.

TypeDirect peer
Description

Dedicated single-disease cancer research and advocacy nonprofit that has built a strong donor community around an underfunded cancer with poor survival rates. A useful comp for Amy's Foundation's strategic position — analogous disease severity, analogous gap in early detection.

TypeDirect peer
Description

High-profile cancer research funding collaborative supporting translational and early detection research. Similar model of channeling donor dollars into named research programs at major medical centers.

TypeBroad incumbent
Description

The dominant breast cancer research and awareness nonprofit, demonstrating the ceiling of a survivor-story-driven, single-disease grantmaking foundation. Comparable GTM motion (race fundraising, survivor storytelling) and grantmaking structure, though in a different cancer.

TypeDirect peer
Description

Ovarian cancer-specific nonprofit supporting biomarker-driven personalized medicine and early detection research. Closely aligned on the diagnostic/biomarker research thesis Amy's Foundation funds at Cleveland Clinic.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Amy's Foundation

Ovarian Cancer Research Nonprofit Foundationamysfoundation.org

Amy's Foundation is a 501(c)(3) nonprofit founded in 2024 in Indiana that funds ovarian cancer early detection research at Cleveland Clinic via community-driven donations, recurring giving, and a survivor advocacy program.

What Amy's Foundation does

Amy's Foundation is a 501(c)(3) nonprofit organization established in 2024 in Fort Wayne, Indiana, by Ron Martin in memory of his late wife Amy Louise Daniels Martin, who carried a BRCA-1 gene mutation and died of ovarian cancer in January 2024. The foundation's singular mission is to fund the development of the first early detection test for ovarian cancer, addressing the gap left by the absence of a screening tool comparable to mammography or Pap smears — a gap that contributes to a 30% five-year survival rate versus 90% for breast cancer and 92% for cervical cancer. The foundation operates a community-driven fundraising model, channeling donations through its website, a Venmo account (@amysfoundation), and the Generosity payment processor, with both one-time and recurring tiers starting at $1 monthly.

The organization's core product is research funding directed to Cleveland Clinic, specifically supporting Dr. Mariam AlHilli's study on integrin/syndecan signaling pathways as potential biomarkers for early detection in BRCA mutation carriers. Its secondary programs include the Amy's Allies volunteer advocacy program, which recruits ovarian cancer survivors and supporters to share personal stories on Instagram, Facebook, LinkedIn, YouTube, and TikTok, and a Salesforce-managed email/newsletter channel used for donor cultivation. The foundation has no proprietary technology product and does not sell goods or services; all revenue derives from charitable donations.

As of the first funding cycle, the foundation has raised approximately $17,482 from 318 donations against a $25,000 goal, deployed a 1-10 employee founder-led operating model, and operates exclusively within the United States. Competitive positioning rests on a tightly focused disease mandate, a personal founder narrative, and a named institutional research partner, rather than on scale advantages or distribution dominance in the broader nonprofit sector.

Amy's Foundation firmographics

Firmographics
Name
Amy's Foundation
Legal name
Amy's Foundation, Inc
Website
https://amysfoundation.org
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
1–10 employees
Short description
Amy's Foundation is a 501(c)(3) nonprofit founded in 2024 in Indiana that funds ovarian cancer early detection research at Cleveland Clinic via community-driven donations, recurring giving, and a survivor advocacy program.
Ownership category
akta.pro rank

Amy's Foundation industry classification

Industry
Product category
Ovarian Cancer Research Nonprofit Foundation
NAICS
Voluntary Health Organizations (813212), Grantmaking Foundations (813211)
akta.pro industry
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking

Keywords

  • Ovarian cancer research
  • Nonprofit fundraising
  • Early detection research
  • Cancer advocacy
  • 501(c)(3) foundation

Where Amy's Foundation is headquartered

Location

Headquarters

HQ city
Fort Wayne
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Amy's Foundation business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Operations, Marketing or Sales, Technology or R&D, Personnel, Others

Revenue model

  1. Donations: The organization accepts one-time and recurring donations through a secure third-party payment processor (Generosity). Donations are tax-deductible as the organization is a 501(c)(3) nonprofit.

Pricing tiers

ModelBillingPrice
OtherOne timeFirst Funding Cycle goal of $25,000 for early detection research
SubscriptionMonthlyRecurring donation options for monthly supporters

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Amy's Foundation product offering

Product offering

Core offering

Amy's Foundation is a 501(c)(3) nonprofit that raises funds to support Cleveland Clinic's research, led by Dr. Mariam AlHilli, aimed at developing the first early detection test for ovarian cancer, with focus on integrin/syndecan biomarkers in BRCA mutation carriers. The foundation collects one-time and recurring donations through its website and Venmo, and runs the Amy's Allies social advocacy program to spread awareness.

Product overview

Amy's Foundation is a 501(c)(3) nonprofit organization focused on funding ovarian cancer early detection research. The organization operates primarily through its website platform, which combines donation collection (via one-time and recurring donation programs) with research advocacy. The core product is funding for Cleveland Clinic's ovarian cancer research, led by Dr. Mariam AlHilli, specifically targeting the development of the first early detection test for ovarian cancer. Supporting offerings include the Amy's Allies social advocacy program where volunteer survivors amplify awareness through social media.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ovarian Cancer Research Funding The foundation's primary mission product: funding Cleveland Clinic's research led by Dr. Mariam AlHilli to develop the first early detection test for ovarian cancer, including the investigation of integrin/syndecan biomarkers in BRCA mutation carriers.
  • Donation Platform Website-based fundraising platform accepting one-time donations to fund ovarian cancer early detection research, processed through the third-party Generosity payment processor.
  • Recurring Donation Program Monthly and weekly giving program allowing donors to contribute recurring amounts starting at $1 per week or month, with options to cover transaction fees, supporting ongoing ovarian cancer research funding.
  • Amy's Allies Program Volunteer social media advocacy program where ovarian cancer survivors and supporters use their digital platforms to spread awareness, share resources, and amplify the foundation's mission year-round and during Ovarian Cancer Awareness Month.

Quantifiable outcome

  • Currently at 70% of first $25,000 funding goal for Cleveland Clinic research
  • +1 more outcomes

Companies that use Amy's Foundation

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Amy's Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Amy's Foundation partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Cleveland CliniccoreStrategic or Co-development PartnerAmy's Foundation is raising funds to support Cleveland Clinic's groundbreaking research to develop the first early detection test for ovarian cancer. The research is led by Dr. Mariam AlHilli and focuses on investigating integrin/syndecan signaling pathways as potential biomarkers for early detection in BRCA mutation carriers. The study aims to examine ovarian tissues and blood samples to identify new detection methods.
  • Dr. Mariam AlHillicoreStrategic or Co-development PartnerDr. Mariam AlHilli is the lead researcher at Cleveland Clinic conducting the early detection ovarian cancer study. Her team is investigating whether changes in cell signaling (integrin/syndecan) found in breast tissues of BRCA mutation carriers are also present in ovarian tissues and whether these changes can serve as new biomarkers for early detection.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Amy's Foundation competitors and assessment

Company assessment

Broad incumbents

  • Breast Cancer Research Foundation (BCRF): Large disease-specific research grantmaking foundation operating a model very similar to Amy's Foundation (donor-funded research grants to academic medical centers), but at vastly greater scale and focused on breast cancer. Useful benchmark for the scale trajectory Amy's Foundation could pursue.
  • American Cancer Society: Largest U.S. cancer nonprofit funding broad research, including ovarian cancer programs. Overlaps with Amy's Foundation in donor pool and research grantmaking category but competes for the same ovarian cancer research dollars at vastly larger scale.
  • Susan G. Komen: The dominant breast cancer research and awareness nonprofit, demonstrating the ceiling of a survivor-story-driven, single-disease grantmaking foundation. Comparable GTM motion (race fundraising, survivor storytelling) and grantmaking structure, though in a different cancer.

Direct peers

  • Ovarian Cancer Research Alliance (OCRA): Largest U.S. nonprofit focused exclusively on ovarian cancer, combining research grantmaking with advocacy and patient support. Directly comparable mission (funding ovarian cancer research) and donor-driven nonprofit model.
  • V Foundation for Cancer Research: Venture-style cancer research grantmaking foundation funding investigator-initiated studies across multiple cancer types. Comparable grantmaking nonprofit model, though broader in scope and substantially larger.
  • National Ovarian Cancer Coalition (NOCC): Long-standing ovarian cancer nonprofit funding research, awareness, and survivor support programs. Mirrors Amy's Foundation's combination of research funding and survivor-led awareness, though at much larger scale.
  • Pancreatic Cancer Action Network (PanCAN): Dedicated single-disease cancer research and advocacy nonprofit that has built a strong donor community around an underfunded cancer with poor survival rates. A useful comp for Amy's Foundation's strategic position — analogous disease severity, analogous gap in early detection.
  • Stand Up To Cancer: High-profile cancer research funding collaborative supporting translational and early detection research. Similar model of channeling donor dollars into named research programs at major medical centers.
  • Clearity Foundation: Ovarian cancer-specific nonprofit supporting biomarker-driven personalized medicine and early detection research. Closely aligned on the diagnostic/biomarker research thesis Amy's Foundation funds at Cleveland Clinic.

Regional players

  • Ovarian Cancer Canada: Canadian national charity dedicated to ovarian cancer research, awareness, and support. Direct mission peer, but operates in a different geography (Canada vs. U.S.) and therefore does not compete for the same donor pool.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Amy's Foundation social profiles

Digital presence

Amy's Foundation compliance and trust

Trust signal

Compliance1 record

Amy's Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Amy's Foundation leadership team

Management profile

Number of profiles

Profiles1 record

Amy's Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Amy's Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amy's Foundation

What does Amy's Foundation do?

Amy's Foundation is a 501(c)(3) nonprofit that raises funds to support Cleveland Clinic's research, led by Dr. Mariam AlHilli, aimed at developing the first early detection test for ovarian cancer, with focus on integrin/syndecan biomarkers in BRCA mutation carriers. The foundation collects one-time and recurring donations through its website and Venmo, and runs the Amy's Allies social advocacy program to spread awareness.

Is Amy's Foundation a public or private company?

Amy's Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Amy's Foundation founded?

Amy's Foundation was founded in 2024. It employs 1 to 10 people.

Where is Amy's Foundation based?

Amy's Foundation is headquartered in Fort Wayne, United States, in the North America region.

How does Amy's Foundation make money?

One revenue line is on record: donations.

Who are Amy's Foundation's main competitors?

Broad incumbents on record are Breast Cancer Research Foundation (BCRF), American Cancer Society and Susan G. Komen. Direct peers are Ovarian Cancer Research Alliance (OCRA), V Foundation for Cancer Research, National Ovarian Cancer Coalition (NOCC), Pancreatic Cancer Action Network (PanCAN), Stand Up To Cancer and Clearity Foundation. Ovarian Cancer Canada is listed as a regional player.

Does Amy's Foundation have an API?

No public API is recorded for Amy's Foundation.

What industry is Amy's Foundation in?

Amy's Foundation's product category is Ovarian Cancer Research Nonprofit Foundation. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813212.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales